These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 8542892

  • 1. Indium-111 pentetreotide scintigraphy in malignant lymphomas.
    Sarda L, Duet M, Zini JM, Berolatti B, Benelhadj S, Tobelem G, Mundler O.
    Eur J Nucl Med; 1995 Oct; 22(10):1105-9. PubMed ID: 8542892
    [Abstract] [Full Text] [Related]

  • 2. Somatostatin receptor scintigraphy in the staging of lymphomas.
    Ivancević V, Wörmann B, Nauck C, Sandrock D, Munz DL, Hiddemann W, Emrich D.
    Leuk Lymphoma; 1997 Jun; 26(1-2):107-14. PubMed ID: 9250794
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin receptor scintigraphy in the initial staging of low-grade non-Hodgkin's lymphomas.
    Lugtenburg PJ, Löwenberg B, Valkema R, Oei HY, Lamberts SW, Eijkemans MJ, van Putten WL, Krenning EP.
    J Nucl Med; 2001 Feb; 42(2):222-9. PubMed ID: 11216520
    [Abstract] [Full Text] [Related]

  • 4. Somatostatin analogue scintigraphy of malignant lymphomas.
    Vanhagen PM, Krenning EP, Reubi JC, Mulder AH, Bakker WH, Oei HY, Löwenberg B, Lamberts SW.
    Br J Haematol; 1993 Jan; 83(1):75-9. PubMed ID: 8094627
    [Abstract] [Full Text] [Related]

  • 5. Radiolabeled octreotide for the demonstration of somatostatin receptors in malignant lymphoma and lymphadenopathy.
    Lipp RW, Silly H, Ranner G, Dobnig H, Passath A, Leb G, Krejs GJ.
    J Nucl Med; 1995 Jan; 36(1):13-8. PubMed ID: 7799065
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin-receptor imaging in lymphoma.
    Goldsmith SJ, Macapinlac HA, O'Brien JP.
    Semin Nucl Med; 1995 Jul; 25(3):262-71. PubMed ID: 7570045
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
    Delcambre C, Reman O, Henry-Amar M, Peny AM, Macro M, Cheze S, Génot JY, Tanguy A, Switsers O, Van HL, Couëtte JE, Leporrier M, Bardet S.
    Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The relevance of somatostatin receptor expression in malignant lymphomas.
    van den Anker-Lugtenburg PJ, Löwenberg B, Lamberts SW, Krenning EP.
    Metabolism; 1996 Aug; 45(8 Suppl 1):96-7. PubMed ID: 8769395
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin receptor scintigraphy in the initial staging of Hodgkin's disease.
    van den Anker-Lugtenburg PJ, Krenning EP, Oei HY, Van Hagen MP, Gerrits CJ, Reubi JC, Lamberts SW, Löwenberg B.
    Br J Haematol; 1996 Apr; 93(1):96-103. PubMed ID: 8611482
    [Abstract] [Full Text] [Related]

  • 12. Visualization of non-Hodgkin's lymphoma by high dosed somatostatin receptor specific scintigraphy and extended single photon emission tomography.
    Lipp RW, Schnedl WJ, Aglas F, Ranner G, Beham-Schmid C, Leb G, Sill H.
    Acta Med Austriaca; 1999 Apr; 26(3):105-8. PubMed ID: 10520379
    [Abstract] [Full Text] [Related]

  • 13. Diagnosis and staging of children's lymphoma using the technetium-labelled somatostatin analogue, 99mTc-depreotide.
    Cholewinski W, Kowalczyk JR, Stefaniak B, Stefaniak J, Poniatowicz-Frasunek E, Tarkowska A.
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):820-4. PubMed ID: 14762697
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Somatostatin receptor-based imaging in malignant lymphomas.
    O'Brien JP.
    J Nucl Med; 1995 Jan; 36(1):19-20. PubMed ID: 7799074
    [No Abstract] [Full Text] [Related]

  • 16. Single photon emission computerized tomography increases the sensitivity of indium-111-pentetreotide scintigraphy in detecting abdominal carcinoids.
    Schillaci O, Scopinaro F, Danieli R, Angeletti S, Tavolaro R, Annibale B, Cannas P, Marignani M, Colella AC, Delle Fave G.
    Anticancer Res; 1997 Jan; 17(3B):1753-6. PubMed ID: 9179229
    [Abstract] [Full Text] [Related]

  • 17. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors.
    Schillaci O, Scopinaro F, Angeletti S, Tavolaro R, Danieli R, Annibale B, Gualdi G, Delle Fave G.
    J Nucl Med; 1996 Sep; 37(9):1452-6. PubMed ID: 8790191
    [Abstract] [Full Text] [Related]

  • 18. Somatostatin receptor scintigraphy to predict the clinical evolution and therapeutic response of thyroid-associated ophthalmopathy.
    Nocaudie M, Bailliez A, Itti E, Bauters C, Wemeau JL, Marchandise X.
    Eur J Nucl Med; 1999 May; 26(5):511-7. PubMed ID: 10382096
    [Abstract] [Full Text] [Related]

  • 19. Early therapy monitoring with FDG-PET in aggressive non-Hodgkin's lymphoma and Hodgkin's lymphoma.
    Torizuka T, Nakamura F, Kanno T, Futatsubashi M, Yoshikawa E, Okada H, Kobayashi M, Ouchi Y.
    Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):22-8. PubMed ID: 14574514
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.